I used to take GERD medicine every day.
So do tens of millions of Americans.
You can buy it at the gas station. Your doctor will write the prescription without much of a conversation. Insurance covers it. The pharmacy refills it on autopilot. Years go by.
I want to talk about what those years cost. And what worked when I stopped.
(Quick note on the name. The medical term is proton pump inhibitor, or PPI. You probably know the brand names. Prilosec. Nexium. Protonix. Prevacid. Generic names: omeprazole, esomeprazole, pantoprazole, lansoprazole. I'll use "GERD medicine" and "PPI" through the rest of this piece. They are the same thing.)
I am a Certified Nutrition Coach, not a physician. I do not diagnose. I do not prescribe. I do not override your doctor. This is my personal story plus a summary of public research. It is not medical advice. Do not stop your GERD medicine without your prescriber's involvement. Rebound acid is real and going off these drugs cold turkey can make things worse.
First, the part that actually matters
Heartburn gets dismissed. It should not be.
Untreated long term reflux damages the lining of the esophagus.
Damaged tissue can change at the cell level. That change is called Barrett's esophagus.
Barrett's is a precursor to esophageal cancer.
About 10 to 20 percent of US adults have weekly GERD symptoms.
So yes. Reflux is serious. Treating it is serious. The question is how.
How GERD medicine actually works
It shuts down the pumps in your stomach lining that make acid. Almost completely.
It works fast. Symptoms calm down. The doctor's job feels done.
Here is the part nobody told me.
GERD medicine was designed for short courses
The FDA approval is for 4 to 8 weeks.
That is not how they are used.
- 25 to 70 percent of GERD medicine prescriptions lack an appropriate medical indication.
- 40 to 55 percent of primary care patients on GERD medicine are on it without a clear reason.
- US adult use more than doubled between 1999 and 2018.
- Over $10 billion a year is spent on prescriptions that, per the literature, should not have been written.
And then there is over the counter. You can buy a long term acid blocker next to the chewing gum. No conversation. No history. No follow up.
What years of acid suppression actually costs
Stomach acid does a lot more than burn food.
It releases vitamin B12 from protein so you can absorb it.
It helps you absorb magnesium, calcium, iron, and zinc.
It kills pathogens before they reach your small intestine.
It triggers the rest of the digestive cascade. Enzymes. Bile. Motility.
Turn that off for years and the documented downstream looks like this:
- Vitamin B12 deficiency. No acid means no B12 released from food.
- Magnesium deficiency. Severe enough cases require IV repletion.
- Bone fractures. Especially in postmenopausal women.
- Chronic kidney disease. Linked in multiple long running cohort studies.
- Higher dementia risk in some populations. Stronger signal in Asian studies. Mixed in Western data.
- C. difficile and other gut infections. No acid means no kill step.
- Associations with gastric and colorectal cancer. Observational, but consistent.
The recent systematic reviews are consistent. Duration of use is the pivotal risk factor.
A few weeks of GERD medicine to heal an acute problem. Probably fine.
A decade of daily use because nobody revisited the prescription. Different conversation.
Here is the part that surprised me
For a lot of people, the problem is not too much acid.
It is not enough.
This sounds backwards. It is not.
How low acid causes reflux
Three mechanisms. All plausible. All described in the functional medicine literature for years.
One. The valve at the top of your stomach (the lower esophageal sphincter, or LES) closes in response to acidic pH. When acid is low, the valve does not close tightly. Whatever acid is there can come back up.
Two. Low acid slows gastric emptying. Food sits longer. It ferments. The gas pushes upward. The valve, already weak, lets some through.
Three. Low acid means undigested food. That feeds bacteria you do not want in the small intestine. Inflammation. Bloating. More upward pressure.
The technical name for low stomach acid is hypochlorhydria.
Conventional gastroenterology calls the evidence for the low acid GERD hypothesis suggestive but not definitive. Fair enough.
The mechanism is real. The pattern shows up in clients. And the standard GERD medicine playbook makes it worse, not better, in those people.
What your genes have to do with this
This is the part most reflux articles do not get to.
Stomach acid production is partly genetic. There are real variants associated with reduced acid output.
- IL1B variants change how much acid your stomach makes. Certain variants lock you into chronic low acid.
- TLR4 +896 A/G. G carriers have an 11 fold higher risk of gastric atrophy and low acid in published research.
- MUC1 short variants reduce the protective mucus lining of the stomach.
- CDX2 expression is tied to intestinal metaplasia, an early step on the road to gastric cancer.
None of these change whether your reflux is real.
They change what your protocol should look like.
Generic acid suppression for a person whose body already makes too little acid is a recipe for the long term risks listed above, without solving the underlying issue.
Your body is not the average body. The protocol should not be the average protocol. Genes first. Blood work second. Symptoms third. Then the plan.
What I did. (With my doctor.)
I want to be clear. I did this with my own physician's involvement.
I am sharing what worked for me. I am not telling you to do the same thing.
1. I tapered off the GERD medicine. Slowly.
Cold turkey would have caused rebound acid. Worse symptoms for weeks. So I worked with my doctor on a step down plan.
2. Hydrogen rich water with meals
A 2018 clinical trial in Journal of Cellular and Molecular Medicine (Franceschelli et al., 84 patients) compared PPI plus tap water to PPI plus hydrogen rich water over three months.
The hydrogen rich water group reported fewer reflux episodes and better oxidative stress markers. One reported metric: about 42 percent fewer heartburn episodes in some subsets.
The proposed mechanism is reduction of oxidative damage in the esophageal tissue itself. So the tissue starts to heal even while reflux is still happening occasionally.
I drank it with meals. I still do.
3. Betaine HCl tabs at meals
This is the part that sounds counterintuitive. I added stomach acid in capsule form.
A 2013 pharmacology study in Molecular Pharmaceutics (Yago et al.) showed 1,500 mg of betaine HCl dropped gastric pH from 5.2 to 0.6 within 30 minutes in healthy volunteers whose acid had been suppressed.
The effect lasts about 73 to 77 minutes. That is your mealtime window.
I started low. One tab with the protein part of a meal. I built up based on how it felt.
This is not for everyone. People with active ulcers should not use it. People on certain medications should not. This is a "work with a practitioner" tool, not a "buy it and start" one.
4. The rest of the gut
None of the above works in isolation.
I worked on what was driving the low acid pattern in the first place.
- Inflammatory foods out. Identified through symptom tracking, not a fad protocol.
- Sleep. Most reflux is worst at night. Most healing happens at night. Sleep was non negotiable.
- Stress. Chronic stress shuts down digestion in measurable ways.
- Gut lining repair. L-glutamine, zinc carnosine, deglycyrrhizinated licorice. Plus removing the things that kept inflaming it.
- H. pylori testing. Important to rule out because untreated H. pylori is one of the strongest predictors of both chronic low acid and gastric cancer.
The part that closed the loop
A few months in, I noticed I needed the HCl tabs less.
A few months after that, I did not need them at all.
My body started making the acid on its own again. On its own pattern, with its own timing. The valve closed the way it was supposed to. The symptoms faded.
That is the part the standard playbook does not usually frame.
The goal is not lifelong acid suppression.
The goal is to find out why your body stopped doing what it knows how to do, and then fix that.
What this means for you
I am not telling you to stop your GERD medicine. I am asking you to ask better questions.
Things worth bringing to your prescriber:
- How long have I been on this? What was the original reason? Is that reason still there?
- Has anyone ever tested my stomach acid level, not just my symptoms?
- Have I been screened for H. pylori? When?
- If I tried to taper off this, what would that look like and how would we monitor?
- If symptoms come back when I taper, are we suppressing them or are we treating the cause?
- Could anything else be driving this? My weight. My sleep position. My alcohol. My stress. Foods I am sensitive to.
And things worth doing on your own:
- Eat earlier in the evening. Three hours before bed if you can.
- Smaller portions. Especially at dinner.
- Sleep on your left side. Anatomy puts your stomach below the esophagus that way.
- Watch what triggers your symptoms. Keep a simple log for two weeks. Patterns show up.
- If you want a closer look at the gene side, the Dirty Gene self assessment screens nine genes including ones involved in inflammation and detox.
Heartburn is not a personality trait. It is a signal. The body is telling you something is not working. Years of acid suppression is silencing the signal without fixing the system.
One last thing
Some people genuinely need long term acid suppression. Severe esophagitis. Confirmed Barrett's. Zollinger Ellison syndrome. Active ulcer healing in specific cases. Some genetic conditions.
GERD medicine is the right tool for those people.
This article is not about them.
This article is about the 40 to 55 percent of people on GERD medicine without a clear reason. The people who tried it once after a bad meal in 2017 and never stopped. The people who buy it at the gas station because heartburn felt like a personality trait. The people whose doctor put it on autopilot.
You deserve a closer look.
That is the work.
Want a closer look at what is driving your reflux?
The intake walks through your symptoms, history, current medications, and the gene panel. We pair that with a recommendation you can bring back to your physician for the medical decisions. The work is collaborative with your medical team, not a replacement for it.
This is one practitioner's opinion and a summary of public research. It is educational, not medical advice. Diagnosis and pharmaceutical management belong with a licensed physician. The Integrative Wellness practice works alongside your medical team, not in place of one. Do not stop your GERD medicine (PPI) without your prescriber's involvement.
Sources & further reading
- Allaqaband H, et al. "Risk Factors for the Development of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis." 2024.
- "Proton Pump Inhibitors: An Evidence-Based Review of Indications, Efficacy, Harms, and Deprescribing." 2024.
- "Long-Term Proton Pump Inhibitor Use and the Risk of Kidney Disease, Dementia, and Fractures: A Systematic Review." Cureus, 2025.
- "Cumulative Use of Proton Pump Inhibitors and Risk of Dementia." Neurology.
- Heidelbaugh JJ, et al. "Use and overuse of proton pump inhibitors." Therapeutic Advances in Gastroenterology.
- "Holistic management of symptomatic reflux: rising to the challenge of proton pump inhibitor overuse." 2022.
- "Trends in use of proton pump inhibitors among adults in the United States from 1999 to 2018." JGIM, 2023.
- Yago MR, et al. "Gastric Re-acidification with Betaine HCl in Healthy Volunteers with Rabeprazole-Induced Hypochlorhydria." Molecular Pharmaceutics, 2013.
- Guilliams TG, Drake LE. "Meal-Time Supplementation with Betaine HCl for Functional Hypochlorhydria: What is the Evidence?" 2020.
- Franceschelli S, et al. "Modulation of the oxidative plasmatic state in gastroesophageal reflux disease with the addition of rich water molecular hydrogen." Journal of Cellular and Molecular Medicine, 2018.
- "Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions." 2010.
- Lynch B. Dirty Genes: A Breakthrough Program to Treat the Root Cause of Illness and Optimize Your Health. HarperOne, 2018.
Why so many people are walking around with this label
Hashimoto's the disease has not gotten more common at the rate the label has. A few reasons.
The symptoms are non-specific. Fatigue, weight gain, brain fog, hair thinning, cold hands, low mood. Those describe Hashimoto's, but they also describe perimenopause, iron deficiency, sleep apnea, depression, chronic stress, post-viral syndromes, and the ordinary wear-and-tear of being a working adult in 2026. Pattern-matching on symptoms alone is not how thyroid disease is diagnosed in the medical literature, but in practice, sometimes it is.
Antibody testing has gotten cheaper and more accessible. Direct-to-consumer labs and functional-medicine clinics test for TPO antibodies routinely. Once a slightly elevated antibody value is on paper, "you have Hashimoto's" sometimes follows, even when the rest of the picture doesn't support it.
And subclinical thyroid changes are sometimes treated as full disease. Here's the number I keep coming back to:
Twenty-one million people. On a medication. They probably don't need.
That stat alone changed how I run intakes. Not because I'm trying to take anyone off their medication (that is a conversation for them and their prescriber), but because it gave me a clearer sense of how often the diagnostic picture deserves a second look from the patient's own physician.
What Hashimoto's actually is
Hashimoto's thyroiditis is an autoimmune condition. The immune system makes antibodies, primarily against thyroid peroxidase (TPO) and sometimes thyroglobulin, and those antibodies slowly damage the thyroid gland's ability to produce hormone.
The disease has stages. In the earliest, antibodies are present but the gland is keeping up. TSH and free T4 look normal, and many people have few or no symptoms for years. Eventually, in some patients, TSH starts to rise (subclinical hypothyroidism), and finally, sometimes, overt hypothyroidism, where TSH is clearly elevated and free T4 has dropped.
The disease can move fast or slow, and it can also stabilize for years at any stage. A positive antibody result is not a sentence. It's a signal worth investigating, not a verdict.
What the literature says about how Hashimoto's is diagnosed
In the medical literature, a Hashimoto's diagnosis is described as the convergence of three things, not one.
1. Antibodies
TPO antibodies are present in roughly 95 percent of Hashimoto's patients. Thyroglobulin antibodies in 60 to 80 percent. About 10 to 15 percent of biopsy-confirmed Hashimoto's cases are seronegative (antibodies absent or low), and tend to be milder forms.
The reverse is what most people don't hear. Elevated TPO antibodies can also occur in healthy people, in other autoimmune conditions, and in transient post-viral states without thyroid disease being present. In my opinion, an isolated positive antibody is a yellow flag, not a finished story.
2. A clinical pattern
Symptoms have to fit thyroid dysfunction (fatigue, cold intolerance, weight changes, hair thinning, slow reflexes, menstrual changes), and ideally there should be either current or progressing biochemical evidence: a TSH outside the functional range, a declining free T4, a rising reverse T3.
3. Imaging when needed
Thyroid ultrasound shows a diffusely heterogeneous, hypoechoic gland in active Hashimoto's. It's not always required, but it can resolve ambiguous cases. The histologic gold standard, biopsy showing lymphocytic infiltration, is rarely necessary outside of nodule investigation.
The full picture is what the literature describes as the diagnostic standard. A single antibody value, on a single day, with no symptom workup or trend data, isn't enough by that standard. Even when it's labeled that way.
The full thyroid panel: TSH, free T4, free T3, reverse T3, TPO antibodies, thyroglobulin antibodies. If labs are borderline, retesting in 8 to 12 weeks before any medication decision is something I encourage clients to bring up with their prescriber. Direct-to-consumer lab services run the full set for $100 to $200.
What I tell clients about Synthroid
Levothyroxine (Synthroid is the most common brand) is a synthetic form of T4. It works. For people with overt hypothyroidism, it is a safe, well-studied, often life-changing medication. The medication itself is not the problem. What I find worth asking about, in my opinion as a non-prescriber, is who is being put on it, whether the workup was complete, and whether they are being monitored after.
About 25 percent of patients on levothyroxine are described in the literature as overtreated (their dose is higher than they need), and overtreatment carries real costs that, in my view, clients deserve to know about.
- Bone density loss. Long-term overtreatment, especially in postmenopausal women, is associated in long-running observational data with accelerated bone loss and increased fracture risk. Rarely part of the initial conversation about starting the medication, but it matters.
- Cardiac arrhythmias. Atrial fibrillation is the most common arrhythmia associated with levothyroxine overtreatment, particularly in patients over 65. Cardiac wall thickness can also increase.
- Anxiety, palpitations, tremors, heat intolerance. The classic running hot symptoms. In my view, these are often worth raising with a prescriber to ask whether the dose is right.
- Hair loss, insomnia, fatigue. Counterintuitively, levothyroxine can produce the same symptoms it was prescribed to fix when the dose is wrong, the form is wrong (some people don't convert T4 to T3 well), or absorption is being interfered with.
- Drug and food interactions. Calcium, iron, magnesium, coffee, soy, fiber, and many medications interfere with absorption. Most clients I see have never been told to take it on an empty stomach with water and wait 30 to 60 minutes before anything else. If your prescriber didn't mention this, in my opinion it's worth asking about.
The deeper issue I see: most people prescribed levothyroxine are never re-evaluated. The follow-up TSH that should happen at 6 to 8 weeks often doesn't. Dosing needs change with weight, age, pregnancy, and menopause. A dose that was right at 35 may not be right at 45.
None of that is a recommendation to stop, change, or skip your medication. It is a list of questions I encourage clients to bring back to their prescriber.
The symptoms, and what they get confused with
Hashimoto's symptoms overlap with a long list of other conditions. The pattern the literature describes as more characteristic tends to be slow, progressive onset over months to years. Not "I felt fine last month and now I don't." Plus a few that are more specific:
- Cold intolerance that's new for you
- Hair thinning at the outer third of the eyebrows (a classic if not universal sign in the literature)
- Persistent muscle aches not explained by activity
- Slow Achilles reflex (easy for a clinician to test, rarely tested)
- Dry skin, brittle nails, slow wound healing
- Constipation that's new or worsening
What I see Hashimoto's get confused with, and what I encourage clients to verify with their physician before accepting it as the only explanation:
- Iron-deficiency anemia. Same fatigue, same hair thinning, same cold intolerance. Most workups check hemoglobin and stop. Ferritin tells the fuller story.
- Vitamin D deficiency. Same fatigue, same low mood, same diffuse aches.
- Perimenopause. Same brain fog, same sleep disruption, same weight redistribution. Often overlaps with thyroid changes. Both can be true at once.
- Sleep apnea. Underdiagnosed in women, and in my opinion responsible for a lot of I'm tired all the time that gets pinned on the thyroid.
- Chronic stress and HPA-axis dysregulation. In my view, the most under-credited cause of thyroid-like symptoms in adults under 50.
- Post-viral syndromes. More common since 2020. They can transiently elevate antibodies and depress thyroid function in ways that resolve without intervention.
The point isn't that Hashimoto's isn't real. It is. The point I want clients to walk away with is that the workup the literature describes is wider than a single antibody test, and in my experience, it's worth asking your physician to widen it.
What the research says about non-medication support
There is a wide gap between what the wellness industry claims you can do for Hashimoto's and what the peer-reviewed evidence supports. Here is a summary of what the research backs, with numbers attached. None of this is a substitute for working with a licensed provider. It is information I share with clients so they can make informed decisions in partnership with their medical team.
Selenium
This is the single best-supported nutritional intervention in the literature. A 2024 meta-analysis in Thyroid (29 cohorts, 2,358 participants) showed selenium supplementation significantly reduced TPO antibodies at both 3 and 6 months, in patients on and off thyroid medication. Effective range described in the trials: 80 to 200 mcg per day, with some studies going up to 400 mcg. Safety is generally good in this range. Higher long-term doses carry their own risks. This is not more is better.
Vitamin D
Vitamin D deficiency (25(OH)D under 20 ng/mL) is associated with TPO antibody levels 40 to 60 percent higher than in vitamin-D-replete patients. Supplementation at 2000 to 4000 IU per day is associated with antibody reductions of 15 to 30 percent, with the effect concentrated in patients who started deficient. Already-replete patients see less benefit. Test before supplementing, and let your physician advise on a target level based on your history.
Myo-inositol plus selenium
Better-studied than most people realize. In a randomized trial of 168 patients with TSH between 3 and 6 and elevated TPO antibodies, the combination of 600 mg myo-inositol plus 83 mcg selenium daily outperformed selenium alone, significantly lowering TSH, reducing antibodies, and raising T3 and T4. Multiple subsequent trials and a 2024 meta-analysis confirm the combination outperforms selenium alone in subclinical Hashimoto's.
Gluten elimination
Honest summary: the evidence is mixed and the overall certainty is low. Some randomized trials in non-celiac Hashimoto's patients show meaningful antibody reductions. One widely-cited trial showed a 24 percent drop in TPO and Tg antibodies at six months on a strict gluten-free diet. Others show no effect or mixed results. Where it works, it tends to work in patients with subclinical celiac, gluten sensitivity, or measurable gut permeability. A 60 to 90 day strict trial, with antibody testing before and after, is in my opinion the most direct way to know whether it matters for you specifically. Worth a conversation with your physician.
Gut healing
The gut-thyroid axis is a real area of research. Chronic dysbiosis, intestinal permeability, and untreated infections (H. pylori, SIBO) have been associated in the literature with worse Hashimoto's outcomes. Working on gut health doesn't cure the disease. In my opinion, it removes one of the chronic immune triggers worth addressing.
Stress, sleep, HPA-axis support
Cortisol dysregulation suppresses T4-to-T3 conversion in the literature, and worsens autoimmune activity. Sleep restriction does the same. The interventions are unglamorous. In my experience working with clients, they often determine whether a supplement protocol moves antibodies at all.
Nutrient repletion
Iron (specifically ferritin), zinc, magnesium, B12. All required for healthy thyroid function and conversion. Depletion in any of these can blunt every other intervention. Test, don't guess. Your physician or a holistic practitioner can help you read the panel.
Where the genes come in
This is where a tuned protocol stops looking like a generic one. The same supplement at the same dose lands very differently in two different bodies, and the genetic patterns that drive that difference are testable.
The patterns I look at first when working with Hashimoto's clients:
- MTHFR. Methylation efficiency. Reduced activity often means the body uses methylated forms of folate and B12 more efficiently than the synthetic versions on the supplement aisle. In my experience, mismatch here is one of the most common reasons clients tell me "I tried a B-complex and felt worse."
- VDR. Vitamin D receptor activity. Patients with VDR variants often need higher doses of vitamin D to reach the same tissue effect, even when serum levels look fine.
- COMT. Catecholamine and estrogen clearance. In my experience, slow COMT plus chronic stress plus estrogen dominance is a common Hashimoto's setup, particularly in women in perimenopause. Slow COMT also affects supplement tolerance. Methyl donors that work for one body can overstimulate another.
- GST and GPX. Glutathione recycling. Variants here suggest a higher need for sulfur-rich foods, NAC, or supplemental glutathione to keep up with autoimmune oxidative load.
None of this changes whether you have Hashimoto's. It changes what your protocol can look like once a diagnosis is confirmed by your physician.
The reason supplementation should match what your body actually needs, not what's popular or what you heard about, is that Hashimoto's is the diagnosis where miscalibration causes the most harm. Iodine without selenium. Folic acid (synthetic) instead of methylfolate. Vitamin D without K2. Each of those is somebody on a wellness blog. Each of them, in my opinion, can make Hashimoto's worse.
When medication is generally indicated (a question for your prescriber, not me)
I want to be precise here, because the anti-medication wellness narrative has, in my opinion, caused real harm. The decision about whether you need Synthroid, or a different dose, or a different formulation, is between you and your prescriber. What I can offer is a summary of what the literature describes.
Levothyroxine is generally indicated when there is overt hypothyroidism (TSH clearly elevated, free T4 below range). The risks of untreated overt hypothyroidism (cardiovascular disease, cognitive decline, infertility, myxedema in severe cases) are higher than the medication's risks. It is also generally indicated in pregnancy, or trying to conceive with antibody-positive thyroid disease, where even subclinical hypothyroidism increases miscarriage risk and the case for treatment is well-established.
It is generally seen as less straightforward in the literature when:
- TSH is mildly elevated on a single test with normal free T4 and there has been no retest at 8 to 12 weeks
- Antibodies are positive but there is no clinical or biochemical hypothyroidism
- Lifestyle and supplementation interventions haven't been trialed for an adequate window
- Symptoms could plausibly be explained by something else that hasn't been ruled out
These are conversations to bring to your prescriber.
If you are already on Synthroid and wondering whether you still need it: please do not stop on your own. Stopping abruptly can cause real cardiovascular and metabolic stress. The right move, in my opinion, is to ask your prescriber for a current TSH, free T4, and free T3 panel, and to bring up that you'd like to revisit whether the dose is still right.
A note on what we're actually doing here
The reason I encourage clients to take a closer look at their Hashimoto's diagnosis isn't because I doubt the disease. It's because, in my opinion, the cost of a wrong fit (years on a medication that may not help and may quietly cause harm) is real. And it's real for women in particular, since they carry most of the prescriptions and most of the bone-density and cardiac risk that follow.
A complete medical workup, in my view, deserves a complete picture. A protocol works best when it is tuned to the actual person, not the average patient. And a medication strong enough to alter cardiac function and bone density, in my opinion, deserves more than a single lab and a refill button.
That's what I tell clients. That's the work.
Wondering if your Hashimoto's diagnosis is the whole story?
If you want a second perspective to bring back to your physician, the intake walks through your full panel, antibody trends, gene results, and current protocol, then lays out an evidence-based plan tuned to your body to be reviewed alongside your medical team.
This is one practitioner's opinion and a summary of public research. It is educational, not medical advice. Diagnosis and pharmaceutical management belong with a licensed physician. The Integrative Wellness practice works alongside your medical team, not in place of one. Do not change a thyroid medication dose without your prescriber's involvement.
Sources & further reading
- "Levothyroxine Use in the United States, 2008 to 2018." Yale School of Medicine summary, 2023.
- Huwiler VV, et al. "Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials." Thyroid, 2024.
- Jiang H, et al. "Effects of vitamin D treatment on thyroid function and autoimmunity markers in patients with Hashimoto's thyroiditis. A meta-analysis of randomized controlled trials." Journal of Clinical Pharmacy and Therapeutics, 2022.
- Nordio M, Pajalich R. "Combined treatment with myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis." Journal of Thyroid Research, 2013. Plus follow-up trials and 2024 meta-analysis.
- Krysiak R, et al. "The effect of gluten-free diet on thyroid autoimmunity in drug-naïve women with Hashimoto's thyroiditis." Experimental and Clinical Endocrinology and Diabetes, 2019.
- American Thyroid Association. "Hashimoto's Thyroiditis. Patient information and clinical references."
- Caturegli P, De Remigis A, Rose NR. "Hashimoto thyroiditis: clinical and diagnostic criteria." Autoimmunity Reviews, 2014.
- Lynch B. Dirty Genes: A Breakthrough Program to Treat the Root Cause of Illness and Optimize Your Health. HarperOne, 2018.